Press Releases

09.30.21
OpGen Initiates Clinical Trial for Unyvero Urinary Tract Infection Panel
09.15.21
OpGen Announces Data from Prospective Randomized Controlled Multicenter Clinical Study Using the Unyvero HPN Panel for Hospitalized Patients with Suspicion of Pneumonia
08.12.21
OpGen Reports Second Quarter 2021 Financial Results and Provides Business Update
08.04.21
OpGen Announces the Cancellation of Adjourned Portion of Annual Meeting
08.04.21
OpGen to Provide Business Update and Financial Results for the Second Quarter 2021 on August 12th at 4:30 p.m. Eastern Time
08.03.21
OpGen Achieves Key Development Milestone in Unyvero A30 RQ Platform Program
07.07.21
OpGen Announces Partial Adjournment of Annual Meeting
06.30.21
OpGen Announces Prospective Clinical Data from Unyvero LRT BAL and Acuitas AMR Gene Panel for Isolates Data Presented at World Microbe Forum
06.28.21
OpGen Group Company Ares Genetics Presents R&D Pipeline Updates
06.09.21
OpGen Announces Partial Adjournment of Annual Meeting for Proposal 2 with All Other Proposals Passed